Mangaluru: Covid has ruined many of our lives. According to study, so far 90 per cent of the total population of India has been attacked by Covid – 19 virus. After intensive research the scientists have come up with vaccination. The Government too made provision for free vaccination for people from the age group 12 to 100 years. However, many people hesitated to get vaccinated due to reports of its side-effect far and wide.
Among very many studies, there is one study that says Cases of myocarditis and pericarditis have been reported after taking Covid-19 mRNA vaccines. The study analysed 1612 cases of myocarditis and 1613 cases of pericarditis that occurred in France in the period from May 12, 2021 to October 31, 2021. They performed matched case-control studies and found increased risks of myocarditis and pericarditis during the first week following vaccination, and particularly after the second dose, with adjusted odds ratios of myocarditis of 8.1 (95% confidence interval [CI], 6.7 to 9.9) for the BNT162b2 and 30 (95% CI, 21 to 43) for the mRNA-1273 vaccine.
European Medicines Agency advised that myocarditis and pericarditis be added to the list of adverse effects of both messenger RNA (mRNA) based vaccines (BNT162b2 [Pfizer–BioNTech] and mRNA-1273 [Moderna]) against Coronavirus disease 2019 (Covid-19). Several reports indicate that adverse events typically occur within a week after injection, mostly after the second dose of vaccine, cluster in young males, and result in a mild clinical course and short duration of hospitalisation.
The risk of myocarditis was substantially increased within the first week post vaccination in both males and females. Odds-ratios associated with the second dose of the mRNA-1273 vaccine were consistently the highest, with values up to 44 (95% CI, 22–88) and 41 (95% CI, 12–140), respectively in males and females aged 18 to 24 years but remaining high in older age groups. Odds-ratios for the second dose of the BNT162b2 vaccine tended to decrease with age, from 18 (95% CI, 9–35) and 7.1 (95% CI, 1.5–33), respectively in males and females aged 12 to 17 years, down to 3.0 (95% CI, 1.5–5.9) and 1.9 (95% CI, 0.39–9.3).
Among exposed cases, the delay between administration of the vaccine and hospitalisation was shorter after the second dose than after the first dose, both for myocarditis (median of 4 days versus 10 days after the BNT162b2 vaccine and of 3.5 days versus 9 days after the mRNA-1273 vaccine) and for pericarditis (median of 6 days versus 10 days after the BNT162b2 vaccine and of 3 days versus 11 days after the mRNA-1273 vaccine).
Speaking to NewsKarnataka Dr. Srinivas Kakkilaya said, “I have shared the information on social media not to scare people but only to create awareness in the society. I am not against the vaccine or the nation. Being a Doctor it’s my duty to share the true inforrmation and medical research with people. This study is done by France, and the samples are taken from the people who took mRNA vaccine. Among those these health consequences have been found. There are lack of safety report regarding the vaccine. The Government and Medical Companies are not sharing the data and information on safety of vaccinated people.”
He also said that Indians need not to be worried as this vaccine is not introduced in our country. “But it is necessary to have exercise caution with regard to vaccine, especially for children. It is the parents wish to vaccinate or not to vaccinate their children. The schools and educational institution should not force the children to get vaccinated. Supreme Court has also order the same. National Technical Advisory Group on Immunization (NTAGI) has also not recommend any vaccine for children with regard to Covid. In India some side-effects of vaccine were found in people who took Covishield but there is no need to worry as the health consequences were found only upto two to three months after taking vaccination.”
This study was conducted nationwide in France and involved a population of 32 million people aged 12 to 50 years having received 46 million doses of mRNA vaccines.
